Incidence of seizures in patients with multiple sclerosis treated with intrathecal baclofen

S. U. Schuele*, C. Kellinghaus, S. J. Shook, N. Boulis, F. A. Bethoux, T. Loddenkemper

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

58 Scopus citations

Abstract

Oral and intrathecal baclofen (ITB) have been associated with epileptic seizures. The authors observed a higher incidence of epileptic seizures in 99 patients with multiple sclerosis (MS) treated with ITB vs a matched control group (7% vs 1%, p < 0.05). Three patients with MS on ITB developed status epilepticus. Seizures were often associated with additional triggering factors.

Original languageEnglish (US)
Pages (from-to)1086-1087
Number of pages2
JournalNeurology
Volume64
Issue number6
DOIs
StatePublished - Mar 22 2005

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Incidence of seizures in patients with multiple sclerosis treated with intrathecal baclofen'. Together they form a unique fingerprint.

Cite this